Capricor Cardiac Stem Cell Therapy Endorsed Through Janssen Deal
This article was originally published in The Pink Sheet Daily
Executive Summary
Janssen inks an option agreement with California-based Capricor, making a tentative bet on the allogeneic stem cell therapy.